[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"adnexal-tumor-of-skin\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:adnexal-tumor-of-skin":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100301962",false,"NCT03210935","French National Database of Rare Dermatological Cancers","French National Database of Rare Dermatological Cancers: Merkel Cell Carcinoma, Inoperable or Metastatic Basal Cell Carcinoma, Cutaneous Adnexal Carcinomas","CARADERM","Inclusion Criteria:\n\n* Patients with histologically confirmed Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, or cutaneous adnexal carcinoma\n\nExclusion Criteria:\n\n* Subjects without Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, or cutaneous adnexal carcinoma\n* Patients refusal","ALL",{"count":18,"type":19},9000,"ESTIMATED","OBSERVATIONAL","Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, and cutaneous adnexal carcinomas are 3 types of rare skin cancers for which much remains unknown in terms of natural behavior, prognosis, treatment and outcomes.\n\nCARADERM is a French prospective national cohort enrolling patients with either one of these 3 tumor types, whose objectives are :\n\n* to provide epidemiological, clinical and socio-economic characteristics of patients\n* to identify new clinical or epidemiological prognostic factors for these rare cancers\n* to evaluate the impact of various treatments on outcomes",[23,24,25],"Adnexal Tumor of Skin","Merkel Cell Carcinoma","Advanced Basal Cell Carcinoma Requiring Systemic Treatment",[27,28,29],"Adnexal cutaneous carcinoma","Merkel cell carcinoma","Advanced basal cell carcinoma requiring systemic treatment","RECRUITING","2026-05-20",{"date":33,"type":34},"2026-05-22","ACTUAL",{"date":36,"type":34},"2015-11-24",{"date":38,"type":19},"2026-12-31",{"name":40,"class":41},"University Hospital, Lille","OTHER",34,""]